Eric Tennant’s oncologist agreed he was a good candidate for a new, FDA-approved treatment since the largest tumor in his body is in his liver. But that’s when his family began fighting another ...

Dana-Farber Cancer Institute is launching Direct Connect for Firefighters, a specialized cancer navigation initiative to meet ...

ARASTEP trial evaluates darolutamide plus ADT for high-risk biochemical recurrence of prostate cancer, focusing on radiologic progression-free survival (rPFS) by PSMA PET-CT. The study involves ...

New research suggests that blood tests known as “liquid biopsies” can improve the treatment of some people with metastatic breast cancer and help their tumors remain under control for more than a year ...

Dr. M. Blair Marshall, thoracic oncology surgeon with the Jellison Cancer Institute, was the first physician on the Gulf Coast to use the technology ...

Dana-Farber Cancer Institute investigators launch a first-of-its kind study to use a novel blood test to identify people who have never used tobacco ...

Participants in the study who test positive for an EGFR mutation will be screened for free at Dana-Farber for lung cancer using a CT scan. If the scan indicates follow-up is needed, trial ...

A CT scan gives a clearer and more precise view Computed tomography (CT) scan is an effective diagnostic tool that uses a series of X-rays to create detailed images of your body. A CT scan gives a ...

May 8, 2025 – If you’ve ever hesitated before getting a CT scan, you’re not alone. A recent study linked 5% of all new cancer cases to radiation exposure from CT scans – a finding that’s ...

from 2:00-2:15 p.m. ET / 1:00-1:15 p.m. CT. The senior author is Robert Haddad, MD, chief of the Division of Head and Neck Oncology and McGraw Chair in Head and Neck Oncology at Dana-Farber.

from 2:00-2:15 p.m. ET / 1:00-1:15 p.m. CT. The senior author is Robert Haddad, MD, chief of the Division of Head and Neck Oncology and McGraw Chair in Head and Neck Oncology at Dana-Farber.

A new study has set off alarm bells, attributing the overuse of computed tomography – or CT – scans to around 5% of new cancer diagnoses annually. Since 2007, this imaging technology has seen ...